Case | Specimen type | Toxin, mg/L | Other findings* | |||||||
---|---|---|---|---|---|---|---|---|---|---|
PMMA | PMA | MDMA | MDA | MAMP | AMP | Cocaine | BE | |||
1 | Postmortem blood† | 1.6 | 0.17 | 2.3 | 0.12 | 0.84 | 0.024 | ND | ND | Lidocaine |
2 | Postmortem blood† | NSQ | NSQ | 3.9 | 0.12 | ND | ND | 0.38 | 3.9 | PMMA vitreous 0.69 mg/L; MDMA vitreous 1.4 mg/L; cannabinoids |
3 | Antemortem blood† | 1.2 | 0.093 | 0.99 | 0.036 | ND | ND | ND | 0.32 | |
4 | Antemortem blood† | 1.6 | 0.098 | 0.52 | 0.021 | ND | ND | ND | ND | Lorazepam |
5 | Postmortem blood† | 1.8 | ND | 0.6 | ND | ND | ND | ND | ND | Morphine, lidocaine, cannabinoids |
6 | Antemortem blood† | 0.11 | 0.023 | 0.14 | 0.015 | ND | ND | ND | ND | Midazolam, temazepam, rocuronium metabolite, acetaminophen |
7 | Antemortem blood† | URP | URP | 0.32 | ND | ND | ND | ND | ND | |
8 | Postmortem IVC blood | 3.33 | 0.42 | 3.09 | 0.17 | 2.28 | 0.07 | ND | ND | Dextromethorphan 0.66 mg/L, acetaminophen 18.2 mg/L, ketamine, oxycodone |
9 | Antemortem serum† | 0.94 | 0.07 | 0.09 | Trace | 0.3 | Trace | ND | ND | |
Postmortem IVC blood | 0.14 | Trace | Trace | Trace | 0.11 | Trace | ND | ND | ||
10 | Antemortem blood† | 2.28 | 0.1 | 0.31 | Trace | 0.75 | Trace | ND | 0.19 | |
Postmortem femoral blood | 4.41 | 0.25 | 0.6 | Trace | 1.47 | Trace | Trace | 0.26 | ||
11 | Antemortem blood† | 0.44 | 0.08 | Trace | Trace | 0.18 | Trace | TNP | TNP | Drug screen not performed (limited specimen) |
12 | Postmortem IVC blood | 3.74 | 0.11 | 1.64 | Trace | ND | ND | ND | ND | Ethanol 30 mg/100 mL |
13 | Antemortem blood† | 1.25 | 0.07 | 0.11 | Trace | 0.35 | Trace | ND | 0.11 | |
Postmortem IVC blood | 2.67 | 0.18 | 0.26 | Trace | 0.8 | Trace | ND | 0.17 | ||
14 | Postmortem IVC blood | 2.7 | 0.12 | 0.29 | Trace | 0.86 | Trace | ND | ND | |
Postmortem central blood | 4.35 | 0.18 | 0.43 | Trace | 1.28 | 0.05 | ND | ND | ||
15 | Postmortem IVC blood | 2.97 | 0.08 | 0.32 | Trace | ND | ND | 0.04 | 0.3 | Acetaminophen 10.6 mg/L, codeine 0.07 mg/L, atropine |
16 | Postmortem IVC blood | 1.67 | 0.15 | 0.27 | Trace | 0.63 | Trace | Trace | 0.2 | Oxycodone (trace), delta-9- tetrahydrocannabinol 2.3 ng/mL, carboxy- tetrahydrocannabinol 11.8 ng/mL |
17 | Postmortem IVC blood | 4.88 | 0.22 | 1.12 | 0.04 | 1.78 | 0.06 | 0.08 | 0.84 | Levamisole, phenacetin |
18 | Postmortem femoral blood | 3.56 | 0.33 | 1.7 | 0.12 | Trace | ND | ND | 0.67 | Benzylpiperazine |
19 | Postmortem central blood | 0.65 | 0.06 | 2.58 | 0.06 | ND | ND | ND | ND | Ethanol 10 mg/100 ml. |
20 | Postmortem femoral blood | 15.7 | 0.75 | 0.65 | Trace | ND | ND | ND | ND | Diphenhydramine |
21 | Postmortem femoral blood | 6.19 | 0.51 | 0.26 | Trace | ND | ND | ND | ND | Dextromethorphan |
22 | Postmortem iliac blood | 5.36 | 1.08 | 0.6 | 0.05 | 1.45 | 0.1 | Trace | 0.11 | Oxycodone 2.01 mg/L, ibuprofen |
23 | Postmortem femoral blood | 6.34 | 0.23 | 0.34 | Trace | ND | ND | Trace | 1.16 | Benzylpiperazine 1.65 mg/L, TFMPP 0.47 mg/L, ketamine, levamisole |
24 | Postmortem femoral blood | 3.58 | 0.23 | 0.16 | Trace | ND | ND | ND | ND | Benzylpiperazine 1.00 mg/L, TFMPP 0.15 mg/L |
25 | Antemortem blood† | 1.6 | 0.1 | 0.14 | Trace | 0.47 | Trace | Trace | 1.09 | Ketamine 0.71 mg/L, midazolam |
26 | Antemortem blood† | 3.27 | 0.09 | 0.16 | Trace | ND | ND | Trace | 0.53 | |
Postmortem iliac blood | 3.83 | 0.14 | 0.19 | Trace | ND | ND | Trace | 0.55 | ||
27 | Postmortem iliac blood | 2.17 | 0.08 | 1 | Trace | ND | ND | 0.05 | 0.46 | Ethanol 10 mg/100 mL, naproxen |
Note: AMP = amphetamine, BE = benzoylecgonine (metabolite of cocaine), IVC = inferior vena cava, MDA = methylenedioxyamphetamine, MAMP = methamphetamine, ND = none detected (below level of detection), NSQ = not sufficient quantities, PMA = paramethoxyamphetamine, TFMPP = trifluoromethylphenylpiperazine , trace = detected but below level of quantitation, TNP = test not performed, URP = urine positive for drug but insufficient antemortem blood available to permit quantitation. *Unless otherwise specified, drugs in this column were not quantitated. †Not otherwise specified.